Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Xenon Pharmaceuticals Inc XENE

Healthcare Biotechnology
Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the... see more

Recent & Breaking News (NDAQ:XENE)

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Provide Corporate Update

GlobeNewswire November 1, 2017

Xenon Pharmaceuticals Announces Initiation of XEN1101 Phase 1 Clinical Trial

GlobeNewswire October 17, 2017

Xenon Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire August 3, 2017

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results and Provide Corporate Update

GlobeNewswire July 27, 2017

15 Biggest Mid-Day Losers For Tuesday

Benzinga.com  June 27, 2017

Xenon Pharmaceuticals to Host Conference Call and Webcast Today at 9:00 a.m. Eastern Time to Discuss Topline Results from TV-45070 Phase 2b Clinical Trial in PHN

GlobeNewswire June 27, 2017

Teva and Xenon Announce Phase II Study of Topical TV-45070 in Patients with Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint

Business Wire June 27, 2017

Xenon Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference

GlobeNewswire June 2, 2017

Xenon Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire May 9, 2017

Investor Network: Xenon Pharmaceuticals Inc. to Host Earnings Call

ACCESS Newswire May 9, 2017

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results and Provide Corporate Update

GlobeNewswire May 4, 2017

Xenon Pharmaceuticals to Present at the 2017 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 28, 2017

Xenon Expands Ion Channel Neurology Pipeline with Acquisition of New Potassium Channel Modulator for the Treatment of Epilepsy

GlobeNewswire April 26, 2017

Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline

Benzinga.com  March 24, 2017

Mid-Morning Market Update: Markets Open Higher; Finish Line Earnings Miss Expectations

Benzinga.com  March 24, 2017

16 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  March 24, 2017

Xenon Pharmaceuticals Announces XEN801 Did Not Meet Efficacy Endpoints in Phase 2 Clinical Trial in Patients with Moderate to Severe Acne

GlobeNewswire March 24, 2017

Xenon Pharmaceuticals Reports 2016 Financial Results and Provides Corporate Update

GlobeNewswire March 8, 2017

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2016 Financial Results and Provide Corporate Update

GlobeNewswire March 1, 2017

Xenon Pharmaceuticals Outlines Key Milestones for 2017

GlobeNewswire January 8, 2017